Search Results - "Carpenter, R.H"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Bedside saccadometry as an objective and quantitative measure of hemisphere-specific neurological function in patients undergoing cranial surgery by Saleh, Y, Marcus, H.J, Iorga, R, Nouraei, R, Carpenter, R.H, Nandi, D

    Published in Journal of clinical neuroscience (01-02-2015)
    “…Abstract Cranial surgery continues to carry a significant risk of neurological complications. New bedside tools that can objectively and quantitatively…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Effects of plasmid-mediated growth hormone releasing hormone supplementation in young, healthy Beagle dogs by Draghia-Akli, R, Cummings, K.K, Khan, A.S, Brown, P.A, Carpenter, R.H

    Published in Journal of animal science (01-09-2003)
    “…Our study focused on the evaluation of the pharmacological and toxicological effects of plasmid-mediated GHRH supplementation with electroporation in normal…”
    Get full text
    Journal Article
  4. 4

    Toxicologic evaluation of injectable acemannan in the mouse, rat and dog by Fogleman, R W, Chapdelaine, J M, Carpenter, R H, McAnalley, B H

    Published in Veterinary and human toxicology (01-06-1992)
    “…Acemannan, the USAN-accepted name for long-chain polydispersed beta-(1,4)-acetylated polymannose with interspersed 0-acetyl groups with a mannose…”
    Get more information
    Journal Article
  5. 5

    Direct inguinal hernia in the cynomolgus monkey (Macaca fascicularis) by Carpenter, R H, Riddle, K E

    Published in Journal of medical primatology (01-01-1980)
    “…The surgical repair of a direct inguinal hernia in Macaca fascicularis using the posterior or preperitoneal approach is presented. The success of this surgical…”
    Get more information
    Journal Article
  6. 6

    Synchronized breeding of cycling ewes to produce fetuses of known gestational age by Spitzer, J C, Carpenter, R H

    Published in Laboratory animal science (Chicago) (01-12-1979)
    “…A treatment regime involving a subcutaneous ear implant containing 3 mg of 17 alpha-acetoxy-11 beta-methyl-19-nor-preg-4-ene-3,20,dione (norgestomet)…”
    Get more information
    Journal Article